Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CLINICAL-RESPONSE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 377 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Weigmann, H; Hartter, S; Maehrlein, S; Kiefer, W; Kramer, G; Dannhardt, G; Hiemke, C
      Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Oosthuizen, P; Emsley, RA
      First-episode psychosis: lessons from 15 years of research

      PRIMARY CARE PSYCHIATRY
    3. Arranz, MJ; Mancama, D; Kerwin, RW
      Neurotransmitter receptor variants and their influence on antipsychotic treatment (Review)

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    4. Mulsant, BH; Pollock, BG; Nebes, R; Miller, MD; Sweet, RA; Stack, J; Houck, PR; Bensasi, S; Mazumdar, S; Reynolds, CF
      A twelve-week, double-blind, randomized comparison of nortriptyline and paroxetine in older depressed inpatients and outpatients

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    5. Alfaro, CL; McClure, RK; Vertrees, JE; Benavides, R
      Unanticipated plasma concentrations in two clozapine-treated patients

      ANNALS OF PHARMACOTHERAPY
    6. Higashiyama, M; Kodama, K; Yokouchi, H; Takami, K; Nakagawa, H; Imamura, F; Minamigawa, K; Kobayashi, H
      Cisplatin-based chemotherapy for postoperative recurrence in non-small cell lung cancer patients: Relation of the in vitro chemosensitive test to clinical response

      ONCOLOGY REPORTS
    7. Weirich, A; Leuschner, I; Harms, D; Vujanic, GM; Troger, J; Abel, U; Graf, N; Schmidt, D; Ludwig, R; Voute, PA
      Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH

      ANNALS OF ONCOLOGY
    8. Masellis, M; Basile, VS; Meltzer, HY; Lieberman, JA; Sevy, S; Goldman, DA; Hamblin, MW; Macciardi, FM; Kennedy, JL
      Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

      SCHIZOPHRENIA RESEARCH
    9. Sackeim, HA; Rush, AJ; George, MS; Marangell, LB; Husain, MM; Nahas, Z; Johnson, CR; Seidman, S; Giller, C; Haines, S; Simpson, RK; Goodman, RR
      Vagus nerve stimulation (VNS (TM)) for treatment-resistant depression: Efficacy, side effects, and predictors of outcome

      NEUROPSYCHOPHARMACOLOGY
    10. Jahns-Streubel, G; Braess, J; Schoch, C; Fonatsch, C; Haase, D; Binder, C; Wormann, B; Buchner, T; Hiddemann, W
      Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF

      LEUKEMIA
    11. Mitchell, PB
      Therapeutic drug monitoring of psychotropic medications

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    12. Kang, UG; Park, KT; Ahn, YM; Koo, YJ; Yoon, SC; Yi, SH; Kim, YS
      Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients - A preliminary study

      PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
    13. Ozdemir, V; Kalow, W; Posner, P; Collins, EJ; Kennedy, JL; Tang, BK; Albers, LJ; Reist, C; Roy, R; Walkes, W; Afra, P
      CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    14. Gaertner, I; Gaertner, HJ; Vonthein, R; Dietz, K
      Therapeutic drug monitoring of clozapine in relapse prevention: A five-year prospective study

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    15. Ulrich, S; Northoff, G; Wurthmann, C; Partscht, G; Pester, U; Herscu, H; Meyer, FP
      Serum levels of amitriptyline and therapeutic effect in non-delusional moderately to severely depressed in-patients: a therapeutic window relationship

      PHARMACOPSYCHIATRY
    16. Sackeim, HA
      The definition and meaning of treatment-resistant depression

      JOURNAL OF CLINICAL PSYCHIATRY
    17. Pilowsky, LS
      Probing targets for antipsychotic drug action with PET and SPET receptor imaging

      NUCLEAR MEDICINE COMMUNICATIONS
    18. Sackeim, HA; Haskett, RF; Mulsant, BH; Thase, ME; Mann, JJ; Pettinati, HM; Greenberg, RM; Crowe, RR; Cooper, TB; Prudic, J
      Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    19. Wagner, KD; Ambrosini, PJ
      Childhood depression: Pharmacological therapy/treatment (pharmacotherapy of childhood depression)

      JOURNAL OF CLINICAL CHILD PSYCHOLOGY
    20. Schneider, ARJ; Stichling, F; Hoffmann, M; Scheler, R; Arnold, JC; Riemann, JF
      Hepatosplenomegaly and progressive neurological symptoms - Late manifestation of Niemann-Pick disease type C - a case report

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    21. Heinemann, V
      Gemcitabine: Progress in the treatment of pancreatic cancer

      ONCOLOGY
    22. Purucker, P; Mertes, H; Goodson, JM; Bernimoulin, JP
      Local versus systemic adjunctive antibiotic therapy in 28 patients with generalized aggressive periodontitis

      JOURNAL OF PERIODONTOLOGY
    23. Menetrier-Caux, C; Thomachot, MC; Alberti, L; Montmain, G; Blay, JY
      IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells

      CANCER RESEARCH
    24. Joukhadar, C; Klein, N; Mader, RM; Schrolnberger, C; Rizovski, B; Heere-Ress, E; Pehamberger, H; Strauchmann, N; Jansen, B; Muller, M
      Penetration of dacarbazine and its active metabolite 5-aminoimidazole-4-carboxamide into cutaneous metastases of human malignant melanoma

      CANCER
    25. Laccourreye, O; Veivers, D; Hans, S; Menard, M; Brasnu, D; Laccourreye, H
      Chemotherapy alone with curative intent in patients with invasive squamouscell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders

      CANCER
    26. Barbui, C; Hotopf, M
      Amitriptyline v. the rest: still the leading antidepressant after 40 yearsof randomised controlled trials

      BRITISH JOURNAL OF PSYCHIATRY
    27. Galmarini, CM; Graham, K; Thomas, X; Calvo, F; Rousselot, P; El Jafaari, A; Cros, E; Mackey, JR; Dumontet, C
      Expression of high Km 5 '-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia

      BLOOD
    28. Bell, R; McLaren, A; Copolov, D
      How reliable are reported plasma clozapine levels?

      AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    29. Lisanby, SH; Schlaepfer, TE; Fisch, HU; Sackeim, HA
      Magnetic seizure therapy at major depression

      ARCHIVES OF GENERAL PSYCHIATRY
    30. Talvik, M; Nordstrom, AL; Nyberg, S; Olsson, H; Halldin, C; Farde, L
      No support for regional selectivity in clozapine-treated patients: A PET study with [C-11]raclopride and [C-11]FLB 457

      AMERICAN JOURNAL OF PSYCHIATRY
    31. Pickar, D; Rubinow, K
      Pharmacogenomics of psychiatric disorders

      TRENDS IN PHARMACOLOGICAL SCIENCES
    32. Choy, EHS; Connolly, DJA; Rapson, N; Jeal, S; Brown, JCC; Kingsley, GH; Panayi, GS; Johnston, JM
      Pharmacokinetic, pharmacodynamic and clinical effects of a humanized IgG1 anti-CD4 monoclonal antibody in the peripheral blood and synovial fluid of rheumatoid arthritis patients

      RHEUMATOLOGY
    33. Drusano, GL; Lode, H; Edwards, JR
      Meropenem: clinical response in relation to in vitro susceptibility

      CLINICAL MICROBIOLOGY AND INFECTION
    34. Hanzen, C; Pieterse, M; Scenczi, O; Drost, M
      Relative accuracy of the identification of ovarian structures in the cow by ultrasonography and palpation per rectum

      VETERINARY JOURNAL
    35. Dougados, M; LeClaire, P; van der Heijde, D; Bloch, DA; Bellamy, N; Altman, RD
      Response criteria for clinical trials on osteoarthritis of the knee and hip - A report of The Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative

      OSTEOARTHRITIS AND CARTILAGE
    36. Fichtenbaum, CJ; Koletar, S; Yiannoutsos, C; Holland, F; Pottage, J; Cohn, SE; Walawander, A; Frame, P; Feinberg, J; Saag, M; Van der Horst, C; Powderly, WG
      Refractory mucosal candidiasis in advanced human immunodeficiency virus infection

      CLINICAL INFECTIOUS DISEASES
    37. Mantovani, G; Maccio, A; Massa, E; Mulas, C; Mudu, MC; Massidda, S; Massa, D; Murgia, V; Ferreli, L; Succu, G; Astara, G; Proto, E; Tore, G; Mura, M; Maxia, G
      Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical outcome, toxicity and organ/function preservation

      INTERNATIONAL JOURNAL OF ONCOLOGY
    38. Corrigan, CJ
      The role of the T cell in the immunopathogenesis of asthma

      IMMUNOLOGICAL MECHANISMS IN ASTHMA AND ALLERGIC DISEASES
    39. Wu, ZY; Smithers, BM; Anderson, C; Roberts, MS
      Can tissue drug concentrations be monitored by microdialysis during or after isolated limb perfusion for melanoma treatment?

      MELANOMA RESEARCH
    40. Bernengo, MG; Quaglino, P; Cappello, N; Lisa, F; Osella-Abate, S; Fierro, MT
      Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients

      MELANOMA RESEARCH
    41. Merimsky, O; Wigler, N; Greif, Y; Schwartz, Y; Asna, N; Paz, J; Mann, A; Inbar, M
      Monthly gemcitabine (days 1, 8 and 15) plus cisplatin (days 1-3) in advanced non-small cell lung cancer: a phase II study

      ANTI-CANCER DRUGS
    42. Cleophas, TJ; Kalmansohn, RB
      Relevance of correlation between treatment responses in clinical trials

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    43. Archambault, D; Beliveau, C; Couture, Y; Carman, S
      Clinical response and immunomodulation following experimental challenge ofcalves with type 2 noncytopathogenic bovine viral diarrhea virus

      VETERINARY RESEARCH
    44. Arranz, MJ; Kerwin, RW
      Neurotransmitter-related genes and antipsychotic response: pharmacogenetics meets psychiatric treatment

      ANNALS OF MEDICINE
    45. Weynants, P
      Immunity and lung cancer: perspectives for an antitumor vaccine

      REVUE DES MALADIES RESPIRATOIRES
    46. Ogawa, N
      Factors affecting levodopa effects in Parkinson's disease

      ACTA MEDICA OKAYAMA
    47. Cirimele, V; Kintz, P; Gosselin, O; Ludes, B
      Clozapine dose-concentration relationships in plasma, hair and sweat specimens of schizophrenic patients

      FORENSIC SCIENCE INTERNATIONAL
    48. Newman, SP; Wilding, IR; Hirst, PH
      Human lung deposition data: the bridge between in vitro and clinical evaluations for inhaled drug products?

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    49. Bohnenstengel, F; Friedel, G; Ritter, CA; McClellan, M; Fritz, P; Eichelbaum, M; Linder, A; Toomes, H; Dierkesmann, R; Kroemer, HK
      Variability of cyclophosphamide uptake into human bronchial carcinoma: consequences for local bioactivation

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    50. Mitchell, PB
      Therapeutic drug monitoring of psychotropic medications

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    51. Johnson, EM; Oakley, KL; Radford, SA; Moore, CB; Warn, P; Warnock, DW; Denning, DW
      Lack of correlation of in vitro amphotericin B susceptibility testing withoutcome in a murine model of Aspergillus infection

      Journal of antimicrobial chemotherapy
    52. Manch-Citron, JN; Lopez, GH; Dey, A; Rapley, JW; MacNeill, SR; Cobb, CM
      PCR monitoring for tetracycline resistance genes in subgingival plaque following site-specific periodontal therapy - A preliminary report

      JOURNAL OF CLINICAL PERIODONTOLOGY
    53. Mans, DRA; Di Leone, L; Caldas, APF; Maino, M; Almeida, L; Cancela, AS; Grivicich, I; da Rocha, AB; Schwartsmann, G
      Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas

      TUMORI
    54. Kondo, T; Mihara, K; Yasui, N; Nagashima, U; Ono, S; Kaneko, S; Ohkubo, T; Osanai, T; Sugawara, K; Otani, K
      Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    55. Fichtenbaum, CJ; Zackin, R; Rajicic, N; Powderly, WG; Wheat, LJ; Zingman, BS
      Amphotericin B oral suspension for fluconazole-refractory oral candidiasisin persons with HIV infection

      AIDS
    56. Aitchison, KJ; Jann, MW; Zhao, JH; Sakai, T; Zaher, H; Wolff, K; Collier, DA; Kerwin, RW; Gonzalez, FJ
      Clozapine pharmacokinetics and pharmacodynamics studied with CYP1A2-null mice

      JOURNAL OF PSYCHOPHARMACOLOGY
    57. Gray, JR; Kagan, J
      The challenge of predicting which children with attention deficit-hyperactivity disorder will respond positively to methylphenidate

      JOURNAL OF APPLIED DEVELOPMENTAL PSYCHOLOGY
    58. Wiernik, PH
      Current status of and future prospects for the medical management of adenocarcinoma of the exocrine pancreas

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    59. Muller, M; Bockenheimer, J; Zellenberg, U; Klein, N; Steger, GG; Eichler, HG; Mader, RM
      Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients

      BREAST CANCER RESEARCH AND TREATMENT
    60. Gex-Fabry, M; Haffen, E; Paintaud, G; Bizouard, P; Sechter, D; Bechtel, PR; Balant, LP
      Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: Model evaluation

      THERAPEUTIC DRUG MONITORING
    61. Palego, L; Marazziti, D; Biondi, L; Giannaccini, G; Sarno, N; Armani, A; Lucacchini, A; Cassano, GB; Dell'Osso, L
      Simultaneous plasma level analysis of clomipramine, N-desmethylclomipramine, and fluvoxamine by reversed-phase liquid chromatography

      THERAPEUTIC DRUG MONITORING
    62. Afonja, O; Smith, JE; Cheng, DM; Goldenberg, AS; Amorosi, E; Shimamoto, T; Nakamura, S; Ohyashiki, K; Ohyashiki, J; Toyama, K; Takeshita, K
      MEIS1 and HOXA7 genes in human acute myeloid leukemia

      LEUKEMIA RESEARCH
    63. Tomson, T; Johannessen, SI
      Therapeutic monitoring of the new antiepileptic drugs

      EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    64. Comella, CL; Jankovic, J; Brin, MF
      Use of botulinum toxin type A in the treatment of cervical dystonia

      NEUROLOGY
    65. Elledge, RM; Green, S; Pugh, R; Allred, DC; Clark, GM; Hill, J; Ravdin, P; Martino, S; Osborne, CK
      Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predictingresponse to tamoxifen in metastatic breast cancer: A Southwest Oncology Group Study

      INTERNATIONAL JOURNAL OF CANCER
    66. Armand, V; Rundfeldt, C; Heinemann, U
      Effects of retigabine (D-23129) on different patterns of epileptiform activity induced by low magnesium in rat entorhinal cortex hippocampal slices

      EPILEPSIA
    67. Matano, E; Tagliaferri, P; Libroia, A; Damiano, V; Fabbrocini, A; De Lorenzo, S; Bianco, AR
      Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study

      BRITISH JOURNAL OF CANCER
    68. Toussaint, M; Luthringer, R; Staner, L; Muzet, A; Macher, JP
      Changes in EEG power density during sleep laboratory adaptation in depressed inpatients

      BIOLOGICAL PSYCHIATRY
    69. Rush, AJ; George, MS; Sackeim, HA; Marangell, LB; Husain, MM; Giller, C; Nahas, Z; Haines, S; Simpson, RK; Goodman, R
      Vagus nerve stimulation (VNS) for treatment-resistant depressions: A multicenter study

      BIOLOGICAL PSYCHIATRY
    70. Masellis, M; Basile, VS; Ozdemir, V; Meltzer, HY; Macciardi, FM; Kennedy, JL
      Pharmacogenetics of antipsychotic treatment: Lessons learned from clozapine

      BIOLOGICAL PSYCHIATRY
    71. Wolfe, F; Zhao, S; Lane, N
      Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients - A survey of 1,799 patients with osteoarthritis,rheumatoid arthritis, and fibromyalgia

      ARTHRITIS AND RHEUMATISM
    72. Sackeim, HA; Prudic, J; Devanand, DP; Nobler, MS; Lisanby, SH; Peyser, S; Fitzsimons, L; Moody, BJ; Clark, J
      A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities

      ARCHIVES OF GENERAL PSYCHIATRY
    73. Kelly, KG; Zisselman, M
      Update on electroconvulsive therapy (ECT) in older adults

      JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    74. Dettling, M; Sachse, C; Brockmoller, J; Schley, J; Muller-Oerlinghausen, B; Pickersgill, I; Rolfs, A; Schaub, RT; Schmider, J
      Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients

      PSYCHOPHARMACOLOGY
    75. Mihara, K; Kondo, T; Suzuki, A; Yasui, N; Nagashima, U; Ono, S; Otani, K; Kaneko, S
      Prolactin response to nemonapride, a selective antagonist for D-2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene

      PSYCHOPHARMACOLOGY
    76. Gitlin, MJ; Nuechterlein, KH; Mintz, J; Fogelson, D; Bartzokis, G; Ventura, J; Subotnik, K; Aravagiri, M
      Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression

      PSYCHOPHARMACOLOGY
    77. Spina, E; Avenoso, A; Facciola, G; Scordo, MG; Ancione, M; Madia, AG; Ventimiglia, A; Perucca, E
      Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics

      PSYCHOPHARMACOLOGY
    78. Joober, R; Benkelfat, C; Brisebois, K; Toulouse, A; Turecki, G; Lal, S; Bloom, D; Labelle, A; Lalonde, P; Fortin, D; Alda, M; Palmour, R; Rouleau, GA
      T102C polymorphism in the 5HT(2A) gene and schizophrenia: relation to phenotype and drug response variability

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    79. Sramek, JJ; Anand, R; Hartman, RD; Schran, HF; Hourani, J; Barto, S; Wardle, TS; Shiovitz, TM; Cutler, NR
      A bioequivalence study of brand and generic clozapine in patients with schizophrenia - Pharmacokinetic and tolerability findings

      CLINICAL DRUG INVESTIGATION
    80. Hu, RJ; Malhotra, AK; Pickar, D
      Predicting response to clozapine - Status of current research

      CNS DRUGS
    81. Staner, L; Luthringer, R; Macher, JP
      Effects of antidepressant drugs on sleep EEG in patients with major depression - Mechanisms and therapeutic implications

      CNS DRUGS
    82. Ghazli, M; Sananes, S; Chopier, J; Touboul, E; Lotz, JP; Antoine, M; Antoine, JM; Uzan, S
      Inflammatory and/or locally advanced breast cancer

      CONTRACEPTION FERTILITE SEXUALITE
    83. Gamelin, E; Boisdron-Celle, M
      Dose monitoring of 5-fluorouracil in patients with colorectal or head and neck cancer - status of the art

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    84. Mantovani, G; Maccio, A; Massa, E; Mulas, C; Mudu, MC; Massidda, S; Massa, D; Murgia, V; Ferreli, L; Succu, G; Astara, G; Proto, E; Tore, G; Mura, M; Maxia, G
      Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: Clinical response and organ/function preservation

      ONCOLOGY REPORTS
    85. Cree, IA; Neale, MH; Myatt, NE; de Takats, PG; Hall, P; Grant, J; Kurbacher, CM; Reinhold, U; Neuber, K; MacKie, RM; Chana, J; Weaver, PC; Khoury, GG; Sartori, C; Andreotti, PE
      Heterogeneity of chemosensitivity of metastatic cutaneous melanoma

      ANTI-CANCER DRUGS
    86. Buur-Rasmussen, B; Brosen, K
      Cytochrome P450 and therapeutic drug monitoring with respect to clozapine

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    87. Weigmann, H; Hartter, S; Fischer, V; Dahmen, N; Hiemke, C
      Distribution of clozapine and desmethylclozapine between blood and brain in rats

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    88. Kelly, DL; Conley, RR; Tamminga, CA
      Differential olanzapine plasma concentrations by sex in a fixed-dose study

      SCHIZOPHRENIA RESEARCH
    89. Gonzalez-Barca, E; Granena, A; Fernandez-Sevilla, A; Moreno, V; Salar, A; Rueda, F; Garcia, J
      Low-dose subcutaneous interleukin-2 in patients with minimal residual lymphoid neoplasm disease

      EUROPEAN JOURNAL OF HAEMATOLOGY
    90. Kelley, ME; Yao, JK; van Kammen, DP
      Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    91. Denney, CB; Rapport, MD
      Predicting methylphenidate response in children with ADHD: Theoretical, empirical, and conceptual models

      JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
    92. van den Borne, BEEM; Landewe, RBM; Rietveld, JH; The, HSG; Griep, EN; Breedveld, FC; Dijkmans, BAC
      Chloroquine therapy in patients with recent-onset rheumatoid arthritis: The clinical response can be predicted by the low level of acute-phase reaction at baseline

      CLINICAL RHEUMATOLOGY
    93. Barfod, TS
      Placebo therapy in dermatology

      CLINICS IN DERMATOLOGY
    94. Gamelin, E; Boissdron-Celle, M; Guerin-Meyer, V; Delva, R; Lortholary, A; Genevieve, F; Larra, F; Ifrah, N; Robert, J
      Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage

      JOURNAL OF CLINICAL ONCOLOGY
    95. Enns, MW
      Re: Predictors of outcome in electroconvulsive therapy

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    96. Callea, V; Stelitano, C; Callea, I; Console, G; Brugiatelli, M; Morabito, F
      In vitro drug-induced cytotoxicity predicts clinical response to high-dosechlorambucil in B-cell chronic lymphocytic leukemia

      HAEMATOLOGICA
    97. Gottschalk, LA
      The application of a computerized measurement of the content analysis of natural language to the assessment of the effects of psychoactive drugs

      METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
    98. Kim, SJ; Sadelain, M; Lee, JS; Seong, RH; Yun, YS; Jang, KJ; Chung, HY
      Adoptive-transfer therapy of tumors with the tumor-specific primary cytotoxic T cells induced in vitro with the B7.1-transduced MCA205 cell line

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    99. Schmitt, U; Dahmen, N; Fischer, V; Weigmann, H; Rao, ML; Reuss, S; Hiemke, C
      Chronic oral haloperidol and clozapine in rats: A behavioral evaluation

      NEUROPSYCHOBIOLOGY
    100. Elias, L; Binder, M; Mangalik, A; Clark, D; Morrison, B; Altobelli, KK; Smith, A
      Pilot trial of infusional 5-fluorouracil, interleukin-2, and subcutaneous interferon-alpha for advanced renal cell carcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:50:55